The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer.

about

The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer.

Item

http://www.wikidata.org/entity/Q55021417

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@en

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@nl

type

Item

label

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@en

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@nl

prefLabel

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@en

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@nl

P1476

The Association of BRAF V600E ...... s in Papillary Thyroid Cancer.

@en

P2093

Forough Foroughi

http://www.w3.org/2001/XMLSchema#string

Maryam Zarkesh

http://www.w3.org/2001/XMLSchema#string

Mehdi Hedayati

http://www.w3.org/2001/XMLSchema#string

S Ahmad Fanaei

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22

Molecular pathogenesis and mechanisms of thyroid cancer

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

MAPK signal pathways in the regulation of cell proliferation in mammalian cells.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

P304

e56120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/IJEM.56120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Azita Zadeh-Vakili

Fereidoun Azizi

P577

2018-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29868127

http://www.w3.org/2001/XMLSchema#string

P932

5972213

http://www.w3.org/2001/XMLSchema#string